TERT promoter hotspot mutations and TERT gene amplification have been reported in phyllodes tumors of the breast, suggesting that these genetic alterations might be the drivers of the progression from benign to malignant lesions in a subset of patients15,22,36. This evidence concerns the gene TERT and breast phyllodes tumor.